Several previous studies have identified RNF43 mutations in diverse cancers, such as colorectal cancers [21], pancreatic ductal adenocarcinoma [26], gastric cancer [27], and intrahepatic cholangiocarcinoma [28]. Here, RNF43 is linked to pancreatic ductal adenocarcinoma.